Compare BJDX & HLSQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BJDX | HLSQ |
|---|---|---|
| Founded | 2015 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 865.6K | 972.0K |
| IPO Year | 2021 | 2018 |
| Metric | BJDX | HLSQ |
|---|---|---|
| Price | $0.83 | $0.29 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 333.6K | ★ 1.2M |
| Earning Date | 11-06-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 86.65 | ★ 560.42 |
| EPS | N/A | ★ 3.56 |
| Revenue | ★ $249,040.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $0.08 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.63 | $0.26 |
| 52 Week High | $7.00 | $0.77 |
| Indicator | BJDX | HLSQ |
|---|---|---|
| Relative Strength Index (RSI) | 42.99 | 11.84 |
| Support Level | $0.82 | $0.26 |
| Resistance Level | $1.06 | $0.45 |
| Average True Range (ATR) | 0.06 | 0.07 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 27.09 | 6.07 |
Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and quicker triage/treatment decisions.
Tessera Defense and Homeland Security Inc develops and acquires technologies that identify, track, and counter physical threats across defense, security, critical infrastructure, and first-response markets - building a portfolio around the growing need for earlier, more accurate threat detection as UAVs and other autonomous systems reshape the operating environment. The Company's portfolio includes Zorronet, an AI-powered autonomous command-and-control platform, and DFSL, a developer of LADAR-based counter-UAS and perimeter security systems.